IP Library Granted Patent US 6,939,689
Granted Patent B2
US 6,939,689 · App. 10/029,221 · Granted Sep 6, 2005

Exonuclease-mediated nucleic acid reassembly in directed evolution

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,939,689
App. No.
10/029,221
Granted
Sep 6, 2005
Kind
B2
Abstract

This invention provides methods of obtaining novel polynucleotides and encoded polypeptides by the use of non-stochastic methods of directed evolution (DirectEvolution™). A particular advantage of exonuclease-mediated reassembly methods is the ability to reassemble nucleic acid strands that would otherwise be problematic to chimerize. Exonuclease-mediated reassembly methods can be used in combination with other mutagenesis methods provided herein. These methods include non-stochastic polynucleotide site-saturation mutagenesis (Gene Site Saturation Mutagenesis™) and non-stochastic polynucleotide reassembly (GeneReassembly™). This invention provides methods of obtaining novel enzymes that have optimized physical &/or biological properties. Through use of the claimed methods, genetic vaccines, enzymes, small molecules, and other desirable molecules can be evolved towards desirable properties. For example, vaccine vectors can be obtained that exhibit increased efficacy for use as genetic vaccines. Vectors obtained by using the methods can have, for example, enhanced antigen expression, increased uptake into a cell, increased stability in a cell, ability to tailor an immune response, and the like. Furthermore, this invention provides methods of obtaining a variety of novel biologically active molecules, in the fields of antibiotics, pharmacotherapeutics, and transgenic traits.

Claims (24)

1. A method for generating a mutagenized polynucleotide comprising:

a) annealing a poly-binding nucleic acid strand to two or more mono-binding nucleic acid strands to generate an annealed heteromeric complex of nucleic acid strands, wherein said annealed complex comprises about 10, 100, 1,000, 10,000, 100,000 or 1,000,000 bases;

b) subjecting unhybridized single-stranded ends of the annealed mono-binding nucleic acid strands in the heteromeric complex to an exonuclease treatment that degrades said unhybridized ends; and

c) subjecting the annealed hertomeric complex to polymerase-based extension.

2. A method for generating a mutagenized polynucleotide comprising:

a) annealing a poly-binding nucleic acid strand to two or more mono-binding nucleic acid strands to generate an annealed heteromeric complex of nucleic acid strands, wherein the mono-binding strands and/or the poly-binding strands are generated from a template progenitor molecule by synthesis, fragmentation, isolation or denaturation;

b) subjecting unhybridized single-stranded ends of the annealed mono-binding nucleic acid strands in the heteromeric complex to an exonuclease treatment that degrades said unhybridized ends; and

c) subjecting the annealed heteromeric complex to polymerase-based extension.

3. A method for generating a mutagenized polynucleotide comprising:

a) annealing a poly-binding nucleic acid strand to two or more mono-binding nucleic acid strands to generate an annealed heteromeric complex of nucleic acid strands, wherein the mono-binding strands and/or the poly-binding strands are derived from a library of clones generated from nucleic acid from a mixed population of organisms;

b) subjecting unhybridized single-stranded ends of the annealed mono-binding nucleic acid strands in the heteromeric complex to an exonuclease treatment that degrades said unhybridized ends; and

c) subjecting the annealed heteromeric complex to polymerase-based extension.

4. The method of claim 3 , wherein the organisms are microorganisms.

5. The method of claim 4 , wherein the microorganisms are a uncultured microorganism.

6. The method of claim 4 , wherein the microorganisms are from environmental sample.

7. The method of claim 1 , further comprising ligating the annealed and extented heteromeric complex.

8. The method of claim 2 , further comprising ligating the annealed and extended heteromeric complex.

9. The method of claim 3 , further comprising ligating the annealed and extended heteromeric complex.

10. A method for generating a mutagenized polynucleotide comprising:

a) annealing a poly-binding nucleic acid strand to two or more mono-binding nucleic acid strands to generate an annealed heteromeric complex of nucleic acid strands, wherein the mono-binding strands and/or the poly-binding strands are derived from a library of clones generated from nucleic acid from a mixed population of uncultured microorganisms from an environmental sample;

b) subjecting unhybridized single-stranded ends of the annealed mono-binding nucleic acid strands in the heteromeric complex to an exonuclease treatment that degrades said unhybridized ends;

c) subjecting the annealed heteromeric complex to polymerase-based extension; and

d) ligating the annealed and extended heteromeric complex.

11. The method of claim 8 , wherein the mono-binding strands and/or the poly-binding strands are generated from a template progenitor molecule by synthesis, fragmentation, isolation or denaturation.

Assignments (2)
CHANGE OF NAME Recorded Jan 21, 2008
From: DIVERSA CORPORATION
To: VERENIUM CORPORATION
Reel/Frame 020393/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2007
From: SHORT, JAY M.; DJAVAKHISHVILI, TSOTNE D.; FREY, GERHARD J.
To: DIVERSA CORPORATION
Reel/Frame 020254/0092 →